Incretin Mimetic

Tirzepatide (5mg) is a dual GIP and GLP-1 receptor agonist designed to study advanced weight loss, lipid metabolism, and glycemic control. Engineered for high potency, this peptide targets dual incretin pathways to optimize metabolic research outcomes. Supplied as a high-purity lyophilized powder for laboratory use.